Skip to content

Inpatient Mortality Prediction Algorithm Clinical Trial (IMPACT)

A Randomized Clinical Trial of a Mortality Prediction Algorithm

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03212534
Acronym
IMPACT
Enrollment
0
Registered
2017-07-11
Start date
2017-07-31
Completion date
2017-10-31
Last updated
2021-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Death, Decompensation, Heart, Decompensation; Heart, Congestive

Keywords

Dascena, patient mortality, machine learning, algorithm, diagnostic

Brief summary

Through the mapping of retrospective patient data into a discrete multidimensional space, a novel algorithm for homeostatic analysis, was built to make outcome predictions. In this prospective study, the ability of the algorithm to predict patient mortality and influence clinical outcomes, will be investigated.

Interventions

OTHERPatient mortality prediction

Healthcare provider is notified of patient mortality prediction.

Sponsors

University of California, San Francisco
CollaboratorOTHER
Dascena
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All adult patients admitted to the participating units will be eligible.

Exclusion criteria

* All patients younger than 18 years of age will be excluded.

Design outcomes

Primary

MeasureTime frame
In-hospital mortalityThrough study completion, an average of 30 days

Secondary

MeasureTime frame
Hospital length of stayThrough study completion, an average of 30 days

Other

MeasureTime frame
Hospital readmissionThrough study completion, an average of 30 days
ICU length of stayThrough study completion, an average of 30 days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026